BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24161906)

  • 1. Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway.
    Song B; Zhang ZZ; Zhong JC; Yu XY; Oudit GY; Jin HY; Lu L; Xu YL; Kassiri Z; Shen WF; Gao PJ; Zhu DL
    Circ J; 2013; 77(12):2997-3006. PubMed ID: 24161906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
    J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts.
    Kuan TC; Chen MY; Liao YC; Ko L; Hong YH; Yen CY; Hsieh WY; Cheng KS; Wu CL; Lin CS
    Biochem Cell Biol; 2013 Dec; 91(6):435-42. PubMed ID: 24219285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
    Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
    Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
    J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways.
    Song B; Jin H; Yu X; Zhang Z; Yu H; Ye J; Xu Y; Zhou T; Oudit GY; Ye JY; Chen C; Gao P; Zhu D; Penninger JM; Zhong JC
    Regul Pept; 2013 Aug; 185():44-51. PubMed ID: 23816468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
    Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
    Jin HY; Song B; Oudit GY; Davidge ST; Yu HM; Jiang YY; Gao PJ; Zhu DL; Ning G; Kassiri Z; Penninger JM; Zhong JC
    PLoS One; 2012; 7(6):e38502. PubMed ID: 22693641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
    Patel VB; Takawale A; Ramprasath T; Das SK; Basu R; Grant MB; Hall DA; Kassiri Z; Oudit GY
    J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
    Chen LJ; Xu YL; Song B; Yu HM; Oudit GY; Xu R; Zhang ZZ; Jin HY; Chang Q; Zhu DL; Zhong JC
    Peptides; 2016 May; 79():49-57. PubMed ID: 27018342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
    Bodiga S; Zhong JC; Wang W; Basu R; Lo J; Liu GC; Guo D; Holland SM; Scholey JW; Penninger JM; Kassiri Z; Oudit GY
    Cardiovasc Res; 2011 Jul; 91(1):151-61. PubMed ID: 21285291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
    Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sirtuin 6 prevents angiotensin II-mediated myocardial fibrosis and injury by targeting AMPK-ACE2 signaling.
    Zhang ZZ; Cheng YW; Jin HY; Chang Q; Shang QH; Xu YL; Chen LX; Xu R; Song B; Zhong JC
    Oncotarget; 2017 Sep; 8(42):72302-72314. PubMed ID: 29069788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of angiotensin converting enzyme II by angiotensin peptides in human cardiofibroblasts.
    Lin CS; Pan CH; Wen CH; Yang TH; Kuan TC
    Peptides; 2010 Jul; 31(7):1334-40. PubMed ID: 20347904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
    Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
    Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.